Traws Pharma, Inc. Current Assets
Traws Pharma, Inc. (TRAW) had Current Assets of $9.02 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-14
- 2026-06-30: Assets, Current $9.02M.
- 2026-03-31: Assets, Current $5.67M.
- 2025-12-31: Assets, Current $7.98M.
- 2025-09-30: Assets, Current $9.63M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $9.02M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $5.67M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $7.98M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $9.63M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $15.37M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $18.86M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $24.95M 10-K · filed 2026-04-15 |
| 2024-09-30 | $8.92M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $18.67M 10-Q · filed 2024-08-15 |
| 2024-03-31 | $18.15M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $22.66M 10-K · filed 2025-03-31 |
| 2023-09-30 | $27.01M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $30.45M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $35.04M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $39.35M 10-K · filed 2024-04-01 |
| 2022-09-30 | $43.75M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $48.03M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $51.38M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $55.43M 10-K · filed 2023-03-30 |
| 2021-09-30 | $59.94M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $44.19M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $48.65M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $19.78M 10-K · filed 2022-03-21 |
| 2020-09-30 | $25.00M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $27.99M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $31.88M 10-Q · filed 2020-05-15 |
| 2019-12-31 | $23.47M 10-K · filed 2021-03-18 |
| 2019-09-30 | $5.80M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $8.43M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $11.19M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $17.77M 10-K · filed 2020-03-27 |
| 2018-09-30 | $23.10M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $30.16M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $8.55M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $4.90M 10-K · filed 2019-04-01 |
| 2017-09-30 | $8.71M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $15.98M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $16.41M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $23.07M 10-K · filed 2018-03-16 |
| 2016-09-30 | $27.90M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $15.99M 10-Q · filed 2016-08-15 |
| 2016-03-31 | $19.41M 10-Q · filed 2016-05-11 |
| 2015-12-31 | $23.18M 10-K · filed 2017-03-29 |
| 2015-09-30 | $25.68M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $27.43M 10-Q · filed 2015-08-13 |
| 2015-03-31 | $36.35M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $46.91M 10-K · filed 2016-03-28 |
| 2014-09-30 | $61.63M 10-Q · filed 2014-11-14 |
| 2014-06-30 | $73.83M 10-Q · filed 2014-08-14 |
| 2014-03-31 | $89.02M 10-Q · filed 2014-05-15 |
| 2013-12-31 | $104.39M 10-K · filed 2015-03-30 |
| 2013-09-30 | $121.93M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $57.05M 10-Q · filed 2013-09-06 |
| 2012-12-31 | $83.25M 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |